ConcertAI
ConcertAI69About
Pricing
View pricing page ↗What does ConcertAI do?
ConcertAI offers generative and agentic AI solutions tailored for life sciences and healthcare products, focusing on regulatory, research, commercial, and clinical development needs. Their platform leverages real-world data to provide precision insights, accelerate clinical trials, and support regulatory-grade evidence and commercial outcomes. Key offerings include the Precision Suite, Commercial Solutions, Clinical Development tools, CancerLinQ, and TeraRecon for advanced medical imaging.
What is ConcertAI's revenue?
StartupHub estimates ConcertAI's annual revenue at $513.5M (range $179.2M to $1.1B, 46% confidence), based on comparable companies in the sector.
What is ConcertAI's valuation?
StartupHub estimates ConcertAI's effective valuation at $1.2B (range $835.0M to $1.6B, 29% confidence), based on comparable companies in the sector.
How much funding has ConcertAI raised?
ConcertAI has raised a total of $300M in funding. The most recent round on record is Series C.
Where is ConcertAI headquartered?
ConcertAI is headquartered in Cambridge, United States.
When was ConcertAI founded?
ConcertAI was founded in 2018.
What industry does ConcertAI operate in?
ConcertAI operates in AI, SaaS, HealthTech, Life Sciences, Agentic AI.
No comments yet. Be the first to share your take.